Cocrystal Pharma, Inc. (COCP) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Palatin Technologies, Inc.

Indaptus Therapeutics, Inc.

Context Therapeutics, Inc.

Entera Bio Ltd.

KALA BIO, Inc.

Acasti Pharma, Inc.

Cocrystal Pharma, Inc.

Genprex, Inc.

AIM ImmunoTech, Inc.

Alzamend Neuro, Inc.

Vincerx Pharma, Inc.

Why is Cocrystal Pharma, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Cocrystal Pharma, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Cocrystal Pharma, Inc.

-35.81%

-0.77

79.17%

S&P 500

25.41%

1.92

13.25%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-100.00%

EBIT Growth (5y)

0.34%

EBIT to Interest (avg)

-11.78

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.92

Sales to Capital Employed (avg)

0.01

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

8.41%

ROCE (avg)

ROE (avg)

0.95%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.85

EV to EBIT

-0.69

EV to EBITDA

-0.69

EV to Capital Employed

6.72

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-976.80%

ROE (Latest)

-126.11%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company

NET SALES(9M)

At USD 0.23 MM has Grown at inf%

OPERATING CASH FLOW(Y)

Highest at USD -8 MM

NET PROFIT(HY)

Higher at USD -4.73 MM

RAW MATERIAL COST(Y)

Fallen by -5,956% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 0.2 times

EPS(Q)

Highest at USD -0.17

-3What is not working for the Company

ROCE(HY)

Lowest at -154.62%

CASH AND EQV(HY)

Lowest at USD 11.86 MM

Here's what is working for Cocrystal Pharma, Inc.

Net Sales

At USD 0.23 MM has Grown at inf%

Year on Year (YoY)

MOJO Watch

Sales trend is very positive

Net Sales (USD MM)

Operating Cash Flow

Highest at USD -8 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit

Higher at USD -4.73 MM

than preceding 12 month period ended Mar 2026

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

EPS

Highest at USD -0.17

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Debtors Turnover Ratio

Highest at 0.2 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -5,956% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Cocrystal Pharma, Inc.

Cash and Eqv

Lowest at USD 11.86 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents